May 13, 2025 | Access to Optimal Care, All News, Awareness and Information, Research and Clinical Trials
Canadian Neuroendocrine Tumor Society launched the Howard D. Trotman NET Patient Assistance Program in honor and loving memory of Howard Trotman who passed away from neuroendocrine cancer in February 2024. As the Support Group Leader for the CNETS Toronto Patient...
May 13, 2025 | Access to Optimal Care, All News, Awareness and Information
The Neuroendocrine Cancer Foundation (NCF, former LACNETS) organized on April 29th, 2025, a webinar on updates about carcinoid heart disease. Cardiologist and congenital heart disease specialist, Dr. Prashanth Venkatesh from Cedars-Sinai Smidt Heart Institute...
May 9, 2025 | All News, Awareness and Information
Neuroendocrine Cancer UK (NCUK) supports the Daily Express Cancer Care campaign ensuring that all cancer patients get access to mental health support both during and after their treatment. Neuroendocrine Cancer UK’s CEO, Catherine Bouvier-Ellis, has written an...
Apr 29, 2025 | Access to Optimal Care, All News, Awareness and Information
March4NETs 2025, now in its second year, united Australians in a nationwide movement to raise awareness and funds for neuroendocrine cancer. Across the country, 98 fundraisers walked, ran, cycled or swam throughout March, collectively covering an impressive 3,620...
Apr 29, 2025 | All News, INCA, Research and Clinical Trials
A new insightful video on NET research was published in the INCA Research web section in April. In a presentation, recorded for INCA in 2024, Dr. Mauro Cives presents the latest updates in translational NET research. He explores the innovative research tools,...
Apr 29, 2025 | All News, Awareness and Information, INCA, Research and Clinical Trials
In April 2025, the Journal of Neuroendocrinology, on behalf of British Society for Neuroendocrinology, informed that the INCA article “Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients” was ranked within the top 10% of...